newsfilter
← Latest News
ACCESS Newswire·

Aspire Biopharma Announces $5.0 Million Share Repurchase Program

ESTERO, FL / ACCESS Newswire / April 27, 2026 / Aspire Biopharma Holdings, Inc. , a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology,